公众号 / 文章神经头颈MR

病例341

Case 341.
PubMed 文献 · Radiology · 2025-01-01

36岁男性,13年复发性多发性硬化病史,接受皮下干扰素-β治疗,因视物模糊1周就诊,血压显著升高至214/122 mm Hg,眼底检查示双侧高血压性视网膜病变,脑MRI新发小脑病灶,实验室检查示微白蛋白尿和高脂血症,临床采取观察等待策略。

要点

  • 多发性硬化患者接受干扰素-β治疗期间出现视物模糊,需鉴别视神经炎与高血压性视网膜病变。
  • 血压显著升高(214/122 mm Hg)伴双侧高血压性视网膜病变,提示高血压急症可能。
  • 新发FLAIR高信号小脑病灶无强化,可能为活动性脱髓鞘病灶,但需结合临床。

核心结论

  • 患者表现为高血压性视网膜病变所致的视物模糊,而非视神经炎;脑MRI示新发小脑病灶,临床采取观察等待策略,未使用激素或抗微生物治疗。

研究设计与样本

  • 病例报告,单例患者,描述临床表现、影像学检查(脑MRI、脊髓MRI)及实验室检查结果。

关键影像表现/征象

  • 1个月前MRI示5个新发FLAIR T2高信号小脑病灶,无强化,提示活动性复发性多发性硬化;本次脑MRI(图2、3)及脊髓MRI(未展示)用于进一步评估;随访增强脑MRI于就诊后1周进行(图4)。

诊断标准与关键数值

  • 原文未报告诊断标准与关键数值。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

A 36-year-old man with known history of relapsing multiple sclerosis of 13-year duration who was undergoing continuous treatment with subcutaneous interferon-β (44 µg three times per week) presented to the emergency department of our hospital with blurry vision of 1-week duration. Routine MRI performed 1 month earlier had revealed five new fluid-attenuated inversion recovery (or FLAIR) T2-hyperintense cerebellar lesions without contrast enhancement, suggesting active relapsing multiple sclerosis (Fig 1), albeit without corresponding neurologic deficits. The patient denied any other symptoms, apart from known yet intensified intermittent tension-type headaches. His history was unremarkable for drug use, recent infections, or travel. There was no routine use of other medication. Apart from a markedly elevated blood pressure (214/122 mm Hg), vital signs were within normal ranges (heart rate, 72 beats per minute; temperature, 97.9 °F [36.6 °C]; respiratory rate, 19 breaths per minute; oxygen saturation, 100%). Physical examination findings were unremarkable. Findings of a neurologic examination were normal, except for known saccadic gaze, with an Expanded Disability Status Scale (or EDSS) of 1. Acute ophthalmologic evaluation with fundoscopy showed bilateral hypertensive retinopathy, without signs of optic neuritis. Laboratory analysis revealed known increased liver enzyme levels due to interferon-β treatment (aspartate aminotransferase level, 123 U/L [2.05 µkat/L]; normal range, 11-34 U/L [0.18-0.57 µkat/L]; alanine aminotransferase level, 179 U/L [2.99 µkat/L]; normal range, 9-59 U/L [0.15-0.99 µkat/L]; γ-glutamyl transferase level, 154 U/L [2.57 µkat/L]; normal range, 12-68 U/L [0.20-1.14 µkat/L]). The patient was admitted for further diagnostic evaluation, including new brain (Figs 2, 3) and spinal (not shown) MRI studies. Antihypertensive treatment with perindopril and amlodipine was initiated. Further laboratory examinations revealed microalbuminuria (albumin-to-creatinine ratio in urine, 59.21 mg/mmol; reference range, <3.00 mg/mmol) and hyperlipidemia (low-density lipoprotein cholesterol level, 3.84 mmol/L; reference range, 1.60-3.40 mmol/L). Blood serologic examination and cerebrospinal fluid laboratory analysis were unremarkable, except for positive oligoclonal bands, with a polymerase chain reaction panel that was negative for common meningitis and/or encephalitis pathogens and a polymerase chain reaction test that was negative for human polyomavirus 2 (or JC virus) DNA in the cerebrospinal fluid. The clinical course supported a wait-and-see approach without the use of steroids or antimicrobial therapy. Follow-up contrast-enhanced brain MRI was performed 1 week after presentation (Fig 4).

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Avramiotis NS, Mutke MA, Mehling M, et al. Case 341. Radiology. 2025. PMID: 40423534. doi:10.1148/radiol.243300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。